Dr. John Cush RheumNow
5 years 4 months ago
Danish registry study of 1,356 psoriasis and 370 PsA pts shows increased odd of coronary disease by CT Calcium scores - psoriasis w CACS ≥ 400 OR 1.25 (1.04-1.50); PsA CACS>0 OR 1.28 (1.00-1.64). Nearly a 49% incr risk in PSO (HR 1.49) https://t.co/jQSAV66TAi
Dr. John Cush RheumNow
5 years 4 months ago
Cross-sectional study RA and PFTs, shows among 2,008 cases, RA was assoc w/ increased odds of restrictive (OR 1.36) & obstructive patterns (OR 1.21) not explained by confounders like smoking. RA had lower predicted FEV1, FVC, FEV1/FVC https://t.co/cVxatLQCG4
Dr. John Cush RheumNow
5 years 4 months ago
Very cool article in Nature - Tissues, not blood, are where immune cells function https://t.co/NCBSBWhjTX
Dr. John Cush RheumNow
5 years 4 months ago
Meet the #SLEEducatorsNetwork in this disease education series where leading rheumatologists and nephrologists share their perspectives on lupus nephritis.
Sponsored by GSK US Medical Affairs
https://t.co/H9BqP9bW4i https://t.co/5AW1IRhBrC
Dr. John Cush RheumNow
5 years 4 months ago
RNL 2021: Best of times, worst of times (Keynote): Dr. Iain McInnes
Dr. Iain McInnes presents his keynote lecture, Best of Times, Worst of Times..., at RheumNow Live 2021.
https://t.co/v3hOYuJZad
Dr. John Cush RheumNow
5 years 4 months ago
We'll be covering EULAR 2021 next week. Look for our coverage from June 3-8. https://t.co/YPNx8MBRn7
Dr. John Cush RheumNow
5 years 4 months ago
Unable to attend the Tuesday Night Rheumatology on RA and vaccines? Watch the replay below.
https://t.co/hUFTjDAnsg https://t.co/ywCRjqg1To
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
Dr. John Cush RheumNow
5 years 4 months ago
Virtual DDW meeting this wk reports claims data comparing IBD to IBD with RA - IBD alone vs IBD w/ RA dx w/ more depression (21% vs 84%), anxiety (20% vs 47%). IBD w/ RA had more depression (OR 7.2); anxiety (OR, 1.25;) or both (OR, 2.3) https://t.co/B78xcJw584
One-third of patients with immune-mediated inflammatory diseases being treated with methotrexate showed attenuated responses to the COVID-19 vaccine, researchers reported.
The NEJM has published the results of a French multicenter study showing that prosthetic joint infections can be successfully managed with 6 weeks of antibiotic therapy; this was noninferior and had better outcomes compared to 12 weeks of antibiotic therapy.
Dr. John Cush RheumNow
5 years 4 months ago
News Feature: CV Risk Decreased with Certain DMARDs in Rheumatoid Arthritis
A large prospective cohort study examined the comparative risks of CVD in patients with RA and found that, MTX, ABA & TNFi use were associated w/ a decreased risk of CV events.
https://t.co/uQbtB76Hgy https://t.co/ftc5ys9C58
Dr. John Cush RheumNow
5 years 4 months ago
Mark your calendars--we'll be covering EULAR 2021 from June 3 through June 8. Over coverage will include new articles, videos, polls and more. https://t.co/LksbsK2TW2
EULAR has published evidence-based recommendations on the use of intra-articular therapies (IAT) based on the literature review and recommendations of a multidisciplinary international task force. These IAT recommendations apply to adult patients with peripheral arthropathies.
